The Journal of Practical Medicine >
Role of complement C3 in early predicting pregnancy outcomes of frozen⁃thawed embryo transfer
Received date: 2023-08-10
Online published: 2024-04-08
Objective To investigate the role of complement C3 in early predicting pregnancy outcomes of frozen-thawed embryo transfer (F-ET). Methods A total of 378 F-ET cycles were prospectively collected and divided into group A (complement C3 ≤ 1.05, 120 cycles) and group B (complement C3 > 1.05, 258 cycles) based on the best cutoff value of complement C3 for predicting F-ET pregnancy outcomes. The outcomes of the two groups were compared, and the best cutoff value of complement C3 for predicting F-ET spontaneous abortion was analyzed in group B. Results Age was a risk factor for successful F-ET pregnancy (P < 0.05), and complement C3 and embryo type were protective factors for successful F-ET pregnancy (P < 0.05). The area under the receiver-operating characteristic curve (ROC) of complement C3 for predicting F-ET pregnancy outcome was 0.702, and the best cutoff value was 1.05 g/L, with a clinical pregnancy sensitivity of 87.60% and a specificity of 52.00%. The clinical pregnancy rate and embryo implantation rate in group B were both significantly higher than those in group A (67.05% vs. 52.75%, P < 0.05). The best cutoff value of complement C3 for predicting spontaneous abortion after F-ET was 1.32 g/L, with an area under the ROC curve of 0.760, a sensitivity of 69.00%, and a specificity of 81.20%. Conclusions Complement C3 is of significance in the early prediction of F-ET pregnancy outcome. When complement C3 exceeds the level of 1.32 g/L, it may lead to an increase in the rate of spontaneous abortion.
Key words: frozen embryo transfer; clinical pregnancy rate; complement C3
Zhixia TANG , Shuangying MA , Ying ZHAGN , Jiajia SHENG , Juan LI , Jingjing HE , Henghua XUAN , Mingyun. HONG . Role of complement C3 in early predicting pregnancy outcomes of frozen⁃thawed embryo transfer[J]. The Journal of Practical Medicine, 2024 , 40(7) : 924 -929 . DOI: 10.3969/j.issn.1006-5725.2024.07.008
| 1 | HILL M J. Recurrent implantation failure: Sapereaude[J]. Fertil Steril, 2021,116(6): 1430-1431. doi:10.1016/j.fertnstert.2021.09.030 |
| 2 | ZHANG T, SHEN H H, QIN X Y, et al. The metabolic characteristic of decidual immune cells and their unique properties in pregnancy loss[J]. Immunol Rev, 2022, 308(1):168-186. doi:10.1111/imr.13085 |
| 3 | FATOBA O, ITOKAZU T, YAMASHITA T. Complement cascade functions during brain development and neurodegeneration[J]. FEBS J, 2022, 289(8): 2085-2109. doi:10.1111/febs.15772 |
| 4 | YUAN K, YE J, LIU Z, et al. Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression[J]. J Exp Clin Cancer Res, 2020, 39(1):9. doi:10.1186/s13046-019-1514-3 |
| 5 | AGOSTINIS C, TEDESCO F, BULLA R. Alternative functions of the complement protein C1q at embryo implantation site[J]. J Reprod Immunol, 2017,119: 74-80. doi:10.1016/j.jri.2016.09.001 |
| 6 | SUGIURA-OGASAWARA M, NOZAWA K, NAKANISHI T, et al. Complement as a predictor of further miscarriage in couples with recurrent miscarriages[J]. Hum Reprod, 2006, 21(10): 2711-2714. doi:10.1093/humrep/del229 |
| 7 | HAMADI G M, LAFTA S F. Immunological parameters of recurrent miscarriages among women in Thi-Qar province[J]. J Med Life, 2022, 15(5):635-639. doi:10.25122/jml-2021-0388 |
| 8 | KENNELLY M A, KILLEEN S L, PHILLIPS C M, et al. Maternal C3 complement and C-reactive protein and pregnancy and fetal outcomes: A secondary analysis of the PEARS RCT-An mHealth-supported, lifestyle intervention among pregnant women with overweight and obesity[J]. Cytokine, 2022, 149:155748. doi:10.1016/j.cyto.2021.155748 |
| 9 | WU J, ZHANG W H, MA J, et al. Prediction of fetal loss in Chinese pregnant patients with systemic lupus erythematosus: a retrospective cohort study[J]. BMJ Open, 2019, 9(2): e023849. doi:10.1136/bmjopen-2018-023849 |
| 10 | NALLI C, LINI D, ANDREOLI L, et al. Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies[J]. Biomedicines, 2021, 9(6): 671. doi:10.3390/biomedicines9060671 |
| 11 | MIHAI A, CHITIMUS D M, JURCUT C, et al. Comparative Analysis of Hematological and Immunological Parameters in Patients with Primary Sj?gren's Syndrome and Peripheral Neuropathy[J]. J Clin Med, 2023,12(11):3672. doi:10.3390/jcm12113672 |
| 12 | 盛佳佳, 戴志俊, 唐志霞,等. GnRH拮抗剂方案新鲜移植周期临床妊娠结局的影响因素分析[J]. 国际生殖健康/计划生育杂志, 2023, 42(1): 7-12. doi:10.12280/gjszjk.20220342 |
| 13 | WU B, ZHOU H G, MENG X Q, et al. Analysis of clinical outcomes of vitrified-warmed embryo transfer after IVF/ICSI at high altitude (3650 m) in Tibet[J]. Reprod Biomed Online, 2022,44(4):699-705. doi:10.1016/j.rbmo.2021.10.013 |
| 14 | ZHANG W Y, JOHAL J K, GARDNER R M, et al. The impact of euploid blastocyst morphology and maternal age on pregnancy and neonatal outcomes in natural cycle frozen embryo transferst[J]. J Assist Reprod Genet, 2022, 39(3): 647-654. doi:10.1007/s10815-022-02423-1 |
| 15 | LI Y, LIU S, LV Q. Single blastocyst stage versus single cleavage stage embryo transfer following fresh transfer: A systematic review and meta-analysis[J]. Eur J Obstet Gynecol Reprod Biol, 2021, 267: 11-17. doi:10.1016/j.ejogrb.2021.10.004 |
| 16 | CLUA E, RODRíGUEZ I, ARROYO G, et al. Blastocyst versus cleavage embryo transfer improves cumulative live birth rates, time and cost in oocyte recipients: a randomized controlled trial[J]. Reprod Biomed Online, 2022, 44(6): 995-1004. doi:10.1016/j.rbmo.2022.01.001 |
| 17 | EFTEKHAR M, MOHAMMADI B, TABIBNEJAD N, et al. Frozen-thawed cleavage stage versus blastocyst stage embryo transfer in high responder patients[J]. Zygote, 2020, 28(6):511-515. doi:10.1017/s0967199420000428 |
| 18 | KONTOPOULOS G, SIMOPOULOU M, ZERVOMANOLAKIS I, et al. Cleavage Stage versus Blastocyst Stage Embryo Transfer in Oocyte Donation Cycles[J]. Medicina (Kaunas), 2019,55(6):293. doi:10.3390/medicina55060293 |
| 19 | 陈曼, 夏汝斌, 林虹, 等. 反复种植失败的子宫内膜异位症患者冻融 胚胎移植结局的影响因素[J]. 实用医学杂志, 2022, 38(9):1071-1075. |
| 20 | SCAMBI C, UGOLINI S, TONELLO M, et al. Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome[J]. Am J Reprod Immunol, 2019,82(6): e13185. doi:10.1111/aji.13185 |
| 21 | CAVAZZANA I, MANUELA N, IRENE C,et al. Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process?[J]. J Autoimmun, 2007, 28(2/3):160-164. doi:10.1016/j.jaut.2007.02.013 |
| 22 | CRISAFULLI F, ANDREOLI L, ZUCCHI D, et al. Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes[J]. J Rheumatol, 2023, jrheum.2022-1135. doi:10.3899/jrheum.2022-1135 |
| 23 | RICHANI K, ROMERO R, SOTO E, et al. Unexplained intrauterine fetal death is accompanied by activation of complement[J]. J Perinat Med, 2005, 33(4): 296-305. doi:10.1515/jpm.2005.052 |
| 24 | DAHM A E A, JACOBSEN E M, WIK H S, et al. Elevated Complement C3 and C4 Levels are Associated with Postnatal Pregnancy-Related Venous Thrombosis[J]. Thromb Haemost, 2019,119(9):1481-1488. doi:10.1055/s-0039-1692426 |
/
| 〈 |
|
〉 |